The University of Glasgow uses cookies for analytics. Find out more about our Privacy policy.
Necessary cookies enable core functionality. The website cannot function properly without these cookies, and can only be disabled by changing your browser preferences.
Analytical cookies help us improve our website. We use Google Analytics. All data is anonymised.
Clarity helps us to understand our users’ behaviour by visually representing their clicks, taps and scrolling. All data is anonymised.
email:
Katrina.Farrell@glasgow.ac.uk
Department of Haematology, Forth Valley Royal Hospital, Stirling Road, Larbert, FK5 4WR
Ghesquières, H. et al. (2018) A susceptibility locus for classical Hodgkin lymphoma at 8q24 near MYC /PVT1 predicts patient outcome in two independent cohorts. British Journal of Haematology, 180(2), pp. 286-290. (doi: 10.1111/bjh.14306) (PMID:27716907) (PMCID:PMC5344766)
Farrell, K., Fyfe, A., Allan, J., Tait, R. C. and Leach, M. (2016) An antithrombin replacement strategy during asparaginase therapy for acute lymphoblastic leukemia is associated with a reduction in thrombotic events. Leukemia and Lymphoma, 57(11), pp. 2568-2574. (doi: 10.3109/10428194.2016.1165815) (PMID:27078747)
Forbes, A., Farrell, K., McKay, P., Bolam, S. and Rule, S. (2013) High dose cytarabine with rituximab is an effective first-line therapy for mantle cell lymphoma and produces ample stem cell harvest yields after multiple chemotherapy cycles. Leukemia and Lymphoma, 54(10), pp. 2303-2305. (doi: 10.3109/10428194.2013.769536)
Farrell, K. and Rule, S. (2012) Mantle-cell lymphoma in the elderly: is it time to CHOP and change? Leukemia and Lymphoma, 53(10), pp. 1855-1856. (doi: 10.3109/10428194.2012.695361)
Farrell, K., McKay, P. and Leach, M. (2011) Nodular lymphocyte predominant Hodgkin lymphoma behaves as a distinct clinical entity with good outcome: evidence from 14-year followup in the West of Scotland Cancer Network. Leukemia and Lymphoma, 52(10), pp. 1920-1928. (doi: 10.3109/10428194.2011.584993)
Farrell, K., Stobo, D. and Soutar, R. (2011) Cervical amyloidoma successfully treated with Bortezomib and Dexamethasone. Journal of Clinical Oncology, 29(17), e512-e513. (doi: 10.1200/JCO.2011.34.6452)
Farrell, K. and Jarrett, R.F. (2011) The molecular pathogenesis of Hodgkin lymphoma. Histopathology, 58(1), pp. 15-25. (doi: 10.1111/j.1365-2559.2010.03705.x)
Ghesquières, H. et al. (2018) A susceptibility locus for classical Hodgkin lymphoma at 8q24 near MYC /PVT1 predicts patient outcome in two independent cohorts. British Journal of Haematology, 180(2), pp. 286-290. (doi: 10.1111/bjh.14306) (PMID:27716907) (PMCID:PMC5344766)
Farrell, K., Fyfe, A., Allan, J., Tait, R. C. and Leach, M. (2016) An antithrombin replacement strategy during asparaginase therapy for acute lymphoblastic leukemia is associated with a reduction in thrombotic events. Leukemia and Lymphoma, 57(11), pp. 2568-2574. (doi: 10.3109/10428194.2016.1165815) (PMID:27078747)
Forbes, A., Farrell, K., McKay, P., Bolam, S. and Rule, S. (2013) High dose cytarabine with rituximab is an effective first-line therapy for mantle cell lymphoma and produces ample stem cell harvest yields after multiple chemotherapy cycles. Leukemia and Lymphoma, 54(10), pp. 2303-2305. (doi: 10.3109/10428194.2013.769536)
Farrell, K. and Rule, S. (2012) Mantle-cell lymphoma in the elderly: is it time to CHOP and change? Leukemia and Lymphoma, 53(10), pp. 1855-1856. (doi: 10.3109/10428194.2012.695361)
Farrell, K., McKay, P. and Leach, M. (2011) Nodular lymphocyte predominant Hodgkin lymphoma behaves as a distinct clinical entity with good outcome: evidence from 14-year followup in the West of Scotland Cancer Network. Leukemia and Lymphoma, 52(10), pp. 1920-1928. (doi: 10.3109/10428194.2011.584993)
Farrell, K., Stobo, D. and Soutar, R. (2011) Cervical amyloidoma successfully treated with Bortezomib and Dexamethasone. Journal of Clinical Oncology, 29(17), e512-e513. (doi: 10.1200/JCO.2011.34.6452)
Farrell, K. and Jarrett, R.F. (2011) The molecular pathogenesis of Hodgkin lymphoma. Histopathology, 58(1), pp. 15-25. (doi: 10.1111/j.1365-2559.2010.03705.x)